Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
Virology
    July 2025
  1. LIU R, Song F, Sun L, Yan F, et al
    Exploring the pathogenic and transmission characteristics of JN.1 in golden hamsters based on different attack methods.
    Virology. 2025;608:110548.
    >> Share

  2. CAO L, Shi S, Zhang C, Zhao C, et al
    A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main protease activity.
    Virology. 2025;608:110540.
    >> Share

    June 2025
  3. CHAKRABORTY C, Bhattacharya M, Abdelhameed AS
    Recent SARS-CoV-2 evolution trajectories indicate the emergence of Omicron's several subvariants and the current rise of KP.3.1.1 and XEC.
    Virology. 2025;607:110508.
    >> Share

  4. ANDERSON M, Lopez J, Wyr M, Ramirez PW, et al
    Defining diverse spike-receptor interactions involved in SARS-CoV-2 entry: Mechanisms and therapeutic opportunities.
    Virology. 2025;607:110507.
    >> Share

  5. BEAUDOIN-BUSSIERES G, Tauzin A, Dionne K, El Ferri O, et al
    Multiple exposures to SARS-CoV-2 Spike enhance cross-reactive antibody-dependent cellular cytotoxicity against SARS-CoV-1.
    Virology. 2025;607:110512.
    >> Share

    May 2025
  6. ISHIGAKI H, Itoh Y
    Translational research on pandemic virus infection using nonhuman primate models.
    Virology. 2025;606:110511.
    >> Share

  7. DAS SARMA J
    Murine beta-coronavirus spike protein: A major determinant of neuropathogenic properties.
    Virology. 2025;606:110499.
    >> Share

  8. LUNDRIGAN E, Uguccioni S, Hum C, Ahmed N, et al
    SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways.
    Virology. 2025;606:110493.
    >> Share

    April 2025
  9. REUSS D, Brown JC, Sukhova K, Furnon W, et al
    Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium.
    Virology. 2025;608:110556.
    >> Share

    March 2025
  10. RAHA JR, Kim KH, Tien Le CT, Bhatnagar N, et al
    A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e.
    Virology. 2025;606:110510.
    >> Share

  11. BANGA NDZOUBOUKOU JL, Kamara AA, Ullah N, Lei Q, et al
    A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults.
    Virology. 2025;606:110509.
    >> Share

  12. OSPINA-JIMENEZ AF, Gomez AP, Rincon-Monroy MA, Perez DR, et al
    A novel reassorted swine H3N2 influenza virus demonstrates an undetected human-to-swine spillover in Latin America and highlights zoonotic risks.
    Virology. 2025;606:110483.
    >> Share

  13. PAWAR SD, Keng SS, Tare DS, Balakrishnan A, et al
    Evidence of novel reassortment in clade 2.3.4.4b avian influenza H5N1 viruses, India, 2024.
    Virology. 2025;606:110482.
    >> Share

  14. LAI SK, Lee ZQ, Tan TI, Tan BH, et al
    Evidence that the cell glycocalyx envelops respiratory syncytial virus (RSV) particles that form on the surface of RSV-infected human airway cells.
    Virology. 2025;604:110415.
    >> Share

  15. HILLS FR, Geoghegan JL, Bostina M
    Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins.
    Virology. 2025;604:110383.
    >> Share

  16. PORTER SM, Hartwig AE, Quilici M, Bosco-Lauth AM, et al
    Intraspecific SARS-CoV-2 Delta variant transmission among red fox (Vulpes vulpes) and striped skunk (Mephitis mephitis).
    Virology. 2025;604:110446.
    >> Share

  17. HE M, He CQ, Ding NZ
    Human viruses: An ever-increasing list.
    Virology. 2025;604:110445.
    >> Share

  18. SHI H, Inankur B, Yin J
    Serum starvation impacts rhinovirus spread from cell to cell.
    Virology. 2025;604:110408.
    >> Share

  19. SUGRUE RJ, Tan BH
    The link between respiratory syncytial virus (RSV) morphogenesis and virus transmission: Towards a paradigm for understanding RSV transmission in the upper airway.
    Virology. 2025;604:110413.
    >> Share

  20. YAMAMOTO A, Ito H, Sakaguchi T, Higashiura A, et al
    Structural insights into nucleocapsid protein variability: Implications for PJ34 efficacy against SARS-CoV-2.
    Virology. 2025;604:110411.
    >> Share

    February 2025
  21. BENLARBI M, Kenfack DD, Dionne K, Cote-Chenette M, et al
    Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.
    Virology. 2025;605:110467.
    >> Share

  22. HARADA R, Hiono T, Igarashi M, Kobayashi D, et al
    Altered receptor-binding specificity of gull-adapted H13 avian influenza viruses corresponds to their unique host preferences.
    Virology. 2025;605:110460.
    >> Share

  23. MILLER JL, Niewiesk S
    Review of impaired immune parameters in RSV infections in the elderly.
    Virology. 2025;603:110395.
    >> Share

  24. JONES LR
    Intra-host variability of SARS-CoV-2: Patterns, causes and impact on COVID-19.
    Virology. 2025;603:110366.
    >> Share

  25. ROY K, Saikia BK, Konwar R
    Exploring the role of carbon quantum dots as countermeasure for SARS-CoV-2 virus.
    Virology. 2025;603:110339.
    >> Share

  26. POPOVIC ME, Tadic V, Popovic M
    (R)evolution of Viruses: Introduction to biothermodynamics of viruses.
    Virology. 2025;603:110319.
    >> Share

    January 2025
  27. FRAGOSO-SAAVEDRA M, Liu Q
    Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies.
    Virology. 2025;604:110412.
    >> Share

  28. PATEL H, Kukol A
    Harnessing viral internal proteins to combat flu and beyond.
    Virology. 2025;604:110414.
    >> Share

  29. HASSAN MSH, Sharif S
    Immune responses to avian influenza viruses in chickens.
    Virology. 2025;603:110405.
    >> Share

  30. NI M, Lin S, Shao Y, Tang J, et al
    Enteric pathogenicity characterization of emerging parainfluenza virus 5 in western China.
    Virology. 2025;604:110409.
    >> Share

  31. ZHAO Y, Li W, Xu L, Tao Z, et al
    Antibody responses in omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2.
    Virology. 2025;603:110404.
    >> Share

  32. SAHA A, Choudhary S, Walia P, Kumar P, et al
    Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction.
    Virology. 2025;604:110394.
    >> Share

  33. LV X, Zheng T, Lei X, Ren L, et al
    RTP4 restricts influenza A virus infection by targeting the viral NS1 protein.
    Virology. 2025;603:110397.
    >> Share

  34. ZHIRNOV OP, Chernyshova AI
    The uncleaved viral hemagglutinin HA0 increases influenza A virus resistance to thermal pasteurization.
    Virology. 2025;604:110389.
    >> Share

  35. SULTANA R, Stahelin RV
    Strengths and limitations of SARS-CoV-2 virus-like particle systems.
    Virology. 2025;601:110285.
    >> Share

    December 2024
  36. CALDERON-PEREZ B, Nunez-Munoz LA, Trejo-Ayala LL, Rosales-Garcia VH, et al
    Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants.
    Virology. 2024;603:110380.
    >> Share

  37. MCKENNA S, Jung KI, Wolf JJ, Seo YJ, et al
    Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication.
    Virology. 2024;603:110367.
    >> Share

  38. OO A, Chen Z, Cao D, Cho YJ, et al
    Biochemical simulation of mutation synthesis and repair during SARS-CoV-2 RNA polymerization.
    Virology. 2024;600:110255.
    >> Share

  39. NOWAK R, Gazecka M, Hoffmann M, Kierzek R, et al
    TMPRSS2-specific antisense oligonucleotides inhibit host cell entry of emerging viruses.
    Virology. 2024;600:110218.
    >> Share

  40. WANG C, Zhang Y, Yang C, Ren W, et al
    Receptor binding mechanism and immune evasion capacity of SARS-CoV-2 BQ.1.1 lineage.
    Virology. 2024;600:110241.
    >> Share

  41. WANG M, Valadez-Ingersoll M, Gilmore TD
    Control of nuclear localization of the nucleocapsid protein of SARS-CoV-2.
    Virology. 2024;600:110232.
    >> Share

    November 2024
  42. YANG S, Yang X, Zhu W, Luo C, et al
    The novel COVID-19 treatment VV116 is a potential inhibitor of Zika virus.
    Virology. 2024;603:110334.
    >> Share

  43. KEGEL NB, Kaufmann A, Matrosovich M, Bauer S, et al
    Decomposition of L-glutamine and accumulation of ammonium in cell culture media inhibit infectivity of influenza viruses.
    Virology. 2024;602:110314.
    >> Share

  44. ZHAO Q, Zhang J, Yang S, Bai X, et al
    H1N1 swine influenza viruses upregulate NEU1 expression through histone H3 acetylation regulated by HDAC2.
    Virology. 2024;601:110305.
    >> Share

    October 2024
  45. WU Y, Lai SK, En-Zuo Chan C, Tan BH, et al
    Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit.
    Virology. 2024;598:110187.
    >> Share

    September 2024
  46. LIU J, Chen K, Wu W, Pang Z, et al
    GRP78 exerts antiviral function against influenza A virus infection by activating the IFN/JAK-STAT signaling.
    Virology. 2024;600:110249.
    >> Share

  47. CHAKRABORTY C, Bhattacharya M
    Evolution and mutational landscape of highly pathogenic avian influenza strain A(H5N1) in the current outbreak in the USA and global landscape.
    Virology. 2024;600:110246.
    >> Share

  48. BENITO AA, Monteagudo LV, Lazaro-Gaspar S, Mazas-Cabetas L, et al
    Detection and subtyping of influenza A virus in porcine clinical samples from Spain in 2020.
    Virology. 2024;600:110223.
    >> Share

  49. ROOT JJ, Porter SM, Lenoch JB, Ellis JW, et al
    Susceptibilities and viral shedding of peridomestic wildlife infected with clade 2.3.4.4b highly pathogenic avian influenza virus (H5N1).
    Virology. 2024;600:110231.
    >> Share

  50. LEI Y, Xu N, Niu C, Chen L, et al
    Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection.
    Virology. 2024;597:110142.
    >> Share

  51. LIANG Z, Wang J, Zhang H, Gao L, et al
    Peptide S4 is an entry inhibitor of SARS-CoV-2 infection.
    Virology. 2024;597:110149.
    >> Share

  52. DUDEK I, Czerkies M, Kwiatek A
    Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus.
    Virology. 2024;597:110127.
    >> Share

    August 2024
  53. RZYMSKI P, Niedziela J, Poniedzialek B, Rosinska J, et al
    Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes.
    Virology. 2024;596:110118.
    >> Share

    July 2024
  54. MANDVIWALA AS, Huckriede ALW, Arankalle VA, Patil HP, et al
    Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice.
    Virology. 2024;598:110194.
    >> Share

  55. CAI M, Wei Z, Hu X, Ji Y, et al
    The evolution, complexity, and diversity of swine influenza viruses in China: A hidden public health threat.
    Virology. 2024;598:110167.
    >> Share

  56. LIU J, Ren T, Wang X, Wang H, et al
    The emergence, isolation, and phylogenetic analysis of a closely related human strain of parainfluenza virus 5 from a case of porcine reproductive and respiratory syndrome in China.
    Virology. 2024;597:110157.
    >> Share

  57. LEE J, Naoe Y, Bang U, Nakagama Y, et al
    Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
    Virology. 2024;595:110067.
    >> Share

  58. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
    Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
    Virology. 2024;595:110082.
    >> Share

  59. UENO S, Amarbayasgalan S, Sugiura Y, Takahashi T, et al
    Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
    Virology. 2024;595:110068.
    >> Share

    June 2024
  60. ZHU H, Li X, Li X, Chen H, et al
    Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide.
    Virology. 2024;597:110162.
    >> Share

  61. NAVEED A, Yu J, Lawson S, Gao R, et al
    Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
    Virology. 2024;597:110138.
    >> Share

  62. NGUYEN CT, Nakayama M, Ishigaki H, Kitagawa Y, et al
    Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaques.
    Virology. 2024;594:110052.
    >> Share

  63. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    >> Share

    May 2024
  64. DUCATEZ MF, Wang C, Yang J, Zhao Y, et al
    Infection dynamics of subtype H9N2 low pathogenic avian influenza a virus in turkeys.
    Virology. 2024;596:110124.
    >> Share

  65. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    >> Share

  66. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
    Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Virology. 2024;596:110117.
    >> Share

  67. HUANG J, Ma K, Zhang J, Zhou J, et al
    Pathogenicity and transmission of novel highly pathogenic H7N2 variants originating from H7N9 avian influenza viruses in chickens.
    Virology. 2024;597:110121.
    >> Share

  68. SAIKIA BK, Roy K, Konwar R
    Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus.
    Virology. 2024;593:110036.
    >> Share

  69. LIU J, Gao L, Zhou N, Jiang Z, et al
    p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2.
    Virology. 2024;593:110018.
    >> Share

    April 2024
  70. MA X, Wang Q, Xu X, Zhang W, et al
    miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
    Virology. 2024;595:110094.
    >> Share

  71. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
    Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Virology. 2024;595:110097.
    >> Share

  72. VALLERIANI F, Di Pancrazio C, Spedicato M, Di Teodoro G, et al
    A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.
    Virology. 2024;592:109997.
    >> Share

  73. ALTINA NH, Maranon DG, Anderson JR, Donaldson MK, et al
    The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells.
    Virology. 2024;592:109986.
    >> Share

    March 2024
  74. BRIGGS K, Chrzastek K, Segovia K, Mo J, et al
    Genetic insertion of mouse Myxovirus-resistance gene 1 increases innate resistance against both high and low pathogenic avian influenza virus by significantly decreasing replication in chicken DF1 cell line.
    Virology. 2024;595:110066.
    >> Share

  75. SAKA N, Nishio M, Ohta K
    Human parainfluenza virus type 2 V protein inhibits mitochondrial apoptosis pathway through two ways.
    Virology. 2024;594:110053.
    >> Share

  76. ZHENG X, Yang R, Zhao Y, Zhang Y, et al
    Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
    Virology. 2024;594:110050.
    >> Share

  77. HUONG TN, Lee ZQ, Lai SK, Lee HY, et al
    Evidence that an interaction between the respiratory syncytial virus F and G proteins at the distal ends of virus filaments mediates efficient multiple cycle infection.
    Virology. 2024;591:109985.
    >> Share

    February 2024
  78. HUANG Y, Zhang P, Han S, Hu B, et al
    Effect of Enteromorpha polysaccharides on gut-lung axis in mice infected with H5N1 influenza virus.
    Virology. 2024;593:110031.
    >> Share

  79. MA B, Tao M, Li Z, Zheng Q, et al
    Mucosal vaccines for viral diseases: Status and prospects.
    Virology. 2024;593:110026.
    >> Share

  80. YANG J, Lan R, Chang H, Li H, et al
    Isolation and characterization of genotype 4 Eurasian avian-like H1N1 influenza virus in pigs suffering from pneumonia.
    Virology. 2024;592:110009.
    >> Share

  81. LEE DW, Kim JM, Kim DW, Kim JY, et al
    Three distinct ORF1a recombinants of the SARS-CoV-2 Delta variant of concern.
    Virology. 2024;590:109945.
    >> Share

    January 2024
  82. FANG K, Song W, Zhang Y, Zheng Y, et al
    Comparative analysis and prediction of avian influenza in Shangrao city, China from 2016 to 2022.
    Virology. 2024;592:109995.
    >> Share

  83. YUAN F, Yang L, Hsiao SH, Herndon NL, et al
    A neonatal piglet model reveals interactions between nasal microbiota and influenza A virus pathogenesis.
    Virology. 2024;592:109996.
    >> Share

  84. ZHANG Y, Wang D, Xiang Q, Hu X, et al
    A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein.
    Virology. 2024;589:109925.
    >> Share

    December 2023
  85. TANG C, Carrera Montoya J, Fritzlar S, Flavel M, et al
    Polyphenol rich sugarcane extract (PRSE) has potential antiviral activity against influenza A virus in vitro.
    Virology. 2023;590:109969.
    >> Share

  86. BIALY D, Richardson S, Chrzastek K, Bhat S, et al
    Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo.
    Virology. 2023;590:109954.
    >> Share

    November 2023
  87. RAMEY AM, Scott LC, Ahlstrom CA, Buck EJ, et al
    Molecular detection and characterization of highly pathogenic H5N1 clade 2.3.4.4b avian influenza viruses among hunter-harvested wild birds provides evidence for three independent introductions into Alaska.
    Virology. 2023;589:109938.
    >> Share

  88. ZHU M, Zeng H, He J, Zhu Y, et al
    Reassortant H9N2 canine influenza viruses containing the pandemic H1N1/2009 ribonucleoprotein complex circulating in pigs acquired enhanced virulence in mice.
    Virology. 2023;589:109927.
    >> Share

  89. NAIQING X, Tang X, Wang X, Cai M, et al
    Hemagglutinin affects replication, stability and airborne transmission of the H9N2 subtype avian influenza virus.
    Virology. 2023;589:109926.
    >> Share

    October 2023
  90. AFRIN SZ, Sathi FA, Nooruzzaman M, Parvin R, et al
    Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution.
    Virology. 2023;587:109882.
    >> Share

    September 2023
  91. BRIGGS K, Sweeney R, Blehert DS, Spackman E, et al
    SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro.
    Virology. 2023;586:122-129.
    >> Share

  92. RAMIREZ KA, Mond J, Papenburg J, Boivin G, et al
    In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections.
    Virology. 2023;586:115-121.
    >> Share

  93. XIAO Y, Wang L, Fang SS, Luo F, et al
    Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo.
    Virology. 2023;586:105-114.
    >> Share

    August 2023
  94. TEWARI DN, Biswas A, Chakrabarti AK, Dutta S, et al
    AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells.
    Virology. 2023;587:109875.
    >> Share

  95. UPRETY T, Sreenivasan CC, Thomas M, Hause B, et al
    Prevalence and characterization of seven-segmented influenza viruses in bovine respiratory disease complex.
    Virology. 2023;587:109859.
    >> Share

  96. YOUK S, Torchetti MK, Lantz K, Lenoch JB, et al
    H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021-April 2022.
    Virology. 2023;587:109860.
    >> Share

  97. MARANO JM, Cereghino C, Finkielstein CV, Weger-Lucarelli J, et al
    An in vitro workflow to create and modify infectious clones using replication cycle reaction.
    Virology. 2023;585:109-116.
    >> Share

  98. SILVA JUNIOR JVJ, Duraes-Carvalho R, de Souza JR, Ramos Janini LM, et al
    Emergence of SARS-CoV-2 serotype(s): Is it a matter of time?
    Virology. 2023;585:78-81.
    >> Share

    July 2023
  99. ZHOU H, Liu J, Li L, Sun J, et al
    Circulation of influenza C virus of C/Sao Paulo/378/82 lineage among pediatric acute respiratory cases, Shandong, China.
    Virology. 2023;587:109855.
    >> Share

    June 2023
  100. TANG L, Liu X, Wang C, Shu C, et al
    USP18 promotes innate immune responses and apoptosis in influenza A virus-infected A549 cells via cGAS-STING pathway.
    Virology. 2023;585:240-247.
    >> Share

  101. SU R, Shi Z, Li E, Zhu M, et al
    A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2.
    Virology. 2023;585:145-154.
    >> Share

  102. YILMAZ B, Cakmak Genc G, Karakas Celik S, Piskin N, et al
    The 3'UTR region of the DNA repair gene PARP-1 May increase the severity of COVID-19 by altering the binding of antiviral miRNAs.
    Virology. 2023;583:29-35.
    >> Share

  103. POTTAGE T, Onianwa O, Atkinson B, Spencer A, et al
    Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature.
    Virology. 2023;583:27-28.
    >> Share

  104. PFANZAGL B
    The ICAM-1 ligand HRV-A89 is internalized independently of clathrin-mediated endocytosis and its capsid reaches late endosomes.
    Virology. 2023;583:45-51.
    >> Share

    May 2023
  105. CHENCHULA S, Amerneni KC, Ghanta MK, Padmavathi R, et al
    Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.
    Virology. 2023;584:38-43.
    >> Share

  106. SUN X, Belser JA, Kieran TJ, Brock N, et al
    Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets.
    Virology. 2023;582:57-61.
    >> Share

  107. MAYER AM, Grohs Ferrareze PA, de Oliveira LFV, Gregianini TS, et al
    Genomic characterization and molecular evolution of SARS-CoV-2 in Rio Grande do Sul State, Brazil.
    Virology. 2023;582:1-11.
    >> Share

    April 2023
  108. BOSCO-LAUTH A, Rodriguez A, Maison RM, Porter SM, et al
    H7N9 influenza A virus transmission in a multispecies barnyard model.
    Virology. 2023;582:100-105.
    >> Share

  109. KANDWAL S, Fayne D
    Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks.
    Virology. 2023;581:97-115.
    >> Share

    March 2023
  110. HUONG TN, Ravi Iyer L, Lui J, Wang Y, et al
    The respiratory syncytial virus SH protein is incorporated into infectious virus particles that form on virus-infected cells.
    Virology. 2023;580:28-40.
    >> Share

    October 2022
  111. LAMICHHANE P, Schmidt ME, Terhuja M, Varga SM, et al
    A live single-cycle RSV vaccine expressing prefusion F protein.
    Virology. 2022;577:51-64.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016